Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Invesco DB Commodity Index Tracking Fund (DBC) vs Medpace Holdings Inc (MEDP) Price & Performance

Invesco DB Commodity Index Tracking FundTrade
Medpace Holdings IncTrade

Price performance (Past 24H)

Key statistics

Invesco DB Commodity Index Tracking Fund vs Medpace Holdings Inc — how do they compare? Invesco DB Commodity Index Tracking Fund trades at $29.97, while Medpace Holdings Inc trades at $609.54 (market cap $16.81B). The key difference: Medpace Holdings Inc is trading nearer its 52-week high, Invesco DB Commodity Index Tracking Fund nearer its low. Which is the better fit depends on your goals.

DBCMEDP
Sector
Commodities - Metals/AgricultureTechnology
52-Week High
$31.69$620.59
52-Week Low
$21.62$393.42
Market Cap
$16.81B
Enterprise Value
$16.43B

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Invesco DB Commodity Index Tracking Fund

DBC trades at $28.91, up 0.17% on the day, with a bearish technical signal from moving averages and neutral oscillators. Financial ratios are unavailable in the provided data. Recent news highlights commodities ETFs as inflation hedges, with articles discussing portfolio strategies and geopolitical impacts on commodity markets.

The outlook for DBC is clouded by bearish technicals and lack of fundamental data. Commodity market volatility from geopolitical tensions offers potential upside, but investors face risks from unclear financial health and market sentiment shifts. Careful evaluation of upcoming earnings and analyst coverage is essential.

Medpace Holdings Inc

MEDP trades at $590.67, up 0.97% on the day, near its consensus price target of $599.57. The stock shows bullish momentum with a golden cross formation and strong institutional interest, while recent Q2 2026 earnings beat estimates with EPS of $4.25 versus $3.98 expected. Revenue growth remains robust, projected to rise from $2.53 billion in 2025 to $2.8 billion in 2026, supporting a premium valuation with a P/E of 35.4.

Outlook is positive given earnings consistency and raised 2026 guidance, but risks include high valuation sensitivity and a shareholder lawsuit investigation. The stock offers growth potential from a strong backlog and net book-to-bill ratio of 1.13x, though investors should monitor legal developments and competitive pressures in medical services.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About Invesco DB Commodity Index Tracking Fund

DBC is a diversified commodity ETF that tracks the DBIQ Optimum Yield Diversified Commodity Index. It invests in futures contracts for 14 heavily traded commodities, including crude oil, gold, and corn, while optimizing for yield and roll costs.

Read more on DBC

About Medpace Holdings Inc

Medpace Holdings, Inc. is a full-service clinical contract research organization (CRO) that provides comprehensive and scientifically-driven clinical development services to the biotechnology, pharmaceutical, and medical device industries. The company specializes in conducting global clinical trials for new drug and medical device approvals. Medpace's model emphasizes therapeutic expertise and a highly integrated approach to accelerate the clinical development process for its clients.

Read more on MEDP